BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ACKR3
11 results:

  • 1. Single-cell RNA sequencing reveals the MIF-ackr3 receptor-ligand interaction between iCAFs and tumor cells in esophageal squamous cell carcinoma.
    Liang J; Lei K; Liang R; Huang J; Tan B; Lin H; Wang M
    Cell Signal; 2024 May; 117():111093. PubMed ID: 38336189
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multidimensional analysis to elucidate the possible mechanism of bone metastasis in breast cancer.
    Yao K; Xiaojun Z; Tingxiao Z; Shiyao L; Lichen J; Wei Z; Yanlei L; Jinlong T; Xiaoyan D; Jun Z; Qing B; Jun L
    BMC Cancer; 2023 Dec; 23(1):1213. PubMed ID: 38066539
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Crosstalk between CXCR4/ackr3 and EGFR Signaling in breast cancer Cells.
    Neves M; Marolda V; Mayor F; Penela P
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233192
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The CXCL12/CXCR4/ackr3 Signaling Axis Regulates PKM2 and Glycolysis.
    Luker KE; Luker GD
    Cells; 2022 May; 11(11):. PubMed ID: 35681470
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Investigating Mechanisms of Response or Resistance to Immune Checkpoint Inhibitors by Analyzing Cell-Cell Communications in Tumors Before and After Programmed Cell Death-1 (PD-1) Targeted Therapy: An Integrative Analysis Using Single-cell RNA and Bulk-RNA Sequencing Data.
    Jiang YQ; Wang ZX; Zhong M; Shen LJ; Han X; Zou X; Liu XY; Deng YN; Yang Y; Chen GH; Deng W; Huang JH
    Oncoimmunology; 2021 Apr; 10(1):1908010. PubMed ID: 33868792
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
    Morein D; Erlichman N; Ben-Baruch A
    Front Immunol; 2020; 11():952. PubMed ID: 32582148
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Role of ackr3 in breast, Lung, and Brain cancer.
    Neves M; Fumagalli A; van den Bor J; Marin P; Smit MJ; Mayor F
    Mol Pharmacol; 2019 Dec; 96(6):819-825. PubMed ID: 30745320
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. breast cancer: An Examination of the Potential of ackr3 to Modify the Response of CXCR4 to CXCL12.
    Del Molino Del Barrio I; Wilkins GC; Meeson A; Ali S; Kirby JA
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30441765
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targeted Imaging of the Atypical Chemokine Receptor 3 (ackr3/CXCR7) in Human cancer Xenografts.
    Behnam Azad B; Lisok A; Chatterjee S; Poirier JT; Pullambhatla M; Luker GD; Pomper MG; Nimmagadda S
    J Nucl Med; 2016 Jun; 57(6):981-8. PubMed ID: 26912435
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells.
    Inaguma S; Riku M; Ito H; Tsunoda T; Ikeda H; Kasai K
    Oncotarget; 2015 Oct; 6(32):33648-57. PubMed ID: 26413813
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting the Atypical Chemokine Receptor ackr3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization.
    Vestal RD; LaJeunesse DR; Taylor EW
    Curr Top Med Chem; 2016; 16(13):1427-40. PubMed ID: 26369825
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.